Hydroxyurea

ATC Code L01XX05

Hydroxyurea

Definition

A monohydroxyl-substituted urea (hydroxycarbamate) antimetabolite. Hydroxyurea selectively inhibits ribonucleoside diphosphate reductase, an enzyme required to convert ribonucleoside diphosphates into deoxyribonucleoside diphosphates, thereby preventing cells from leaving the G1/S phase of the cell cycle. This agent also exhibits radiosensitizing activity by maintaining cells in the radiation-sensitive G1 phase and interfering with DNA repair. (NCI04)

Also known as Droxia, Hydrea, Hydroxycarbamide, HYDROXYUREA, Litalir, Onco-Carbide, Oncocarbide, Oxeron, SQ 1089, SQ-1089, Syrea, WR 83799 — per NCIT

Also identified as

Indications

Disease Relation Source
Acquired polycythemia vera may treat MEDRT · Public domain (U.S. Government work)
Brain cancer may treat MEDRT · Public domain (U.S. Government work)
Essential thrombocythemia may treat MEDRT · Public domain (U.S. Government work)
Hypereosinophilic syndrome may treat MEDRT · Public domain (U.S. Government work)
Melanoma may treat MEDRT · Public domain (U.S. Government work)
Non-small cell lung carcinoma may treat MEDRT · Public domain (U.S. Government work)
Ovarian cancer may treat MEDRT · Public domain (U.S. Government work)
Prostate cancer may treat MEDRT · Public domain (U.S. Government work)
Psoriasis may treat MEDRT · Public domain (U.S. Government work)
Renal cell carcinoma may treat MEDRT · Public domain (U.S. Government work)
Squamous cell carcinoma may treat MEDRT · Public domain (U.S. Government work)
Uterine cancer may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Bone marrow may treat a disease of this organ DERIVED · CC BY 4.0
Lungs may treat a disease of this organ DERIVED · CC BY 4.0
Skin of body may treat a disease of this organ DERIVED · CC BY 4.0

3 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.